GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eupraxia Pharmaceuticals Inc (NAS:EPRX) » Definitions » Total Noninterest Expense

EPRX (Eupraxia Pharmaceuticals) Total Noninterest Expense


View and export this data going back to 2021. Start your Free Trial

What is Eupraxia Pharmaceuticals Total Noninterest Expense?

Total Noninterest Expense only applies to banks.


Eupraxia Pharmaceuticals Business Description

Traded in Other Exchanges
Address
201-2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.